Pediatrix Medical Group (NYSE:MD) Shares Up 7.5%

Shares of Pediatrix Medical Group, Inc. (NYSE:MD) were up 7.5% during trading on Tuesday . The company traded as high as $9.98 and last traded at $9.98. Approximately 41,582 shares were traded during mid-day trading, a decline of 94% from the average daily volume of 672,949 shares. The stock had previously closed at $9.28.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on the stock. Truist Financial reduced their price objective on shares of Pediatrix Medical Group from $10.50 to $10.00 and set a “hold” rating on the stock in a research note on Wednesday, February 21st. Mizuho cut their price objective on Pediatrix Medical Group from $10.00 to $9.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 21st. TheStreet lowered Pediatrix Medical Group from a “c” rating to a “d” rating in a research report on Friday, February 23rd. Finally, Jefferies Financial Group dropped their price target on Pediatrix Medical Group from $10.00 to $9.00 and set a “hold” rating on the stock in a research report on Wednesday, March 6th. Five analysts have rated the stock with a hold rating, Based on data from MarketBeat.com, Pediatrix Medical Group presently has an average rating of “Hold” and a consensus price target of $9.38.

Pediatrix Medical Group Stock Performance

The company’s 50-day simple moving average is $9.21 and its 200-day simple moving average is $9.38. The stock has a market cap of $686.49 million, a price-to-earnings ratio of -11.19, a price-to-earnings-growth ratio of 2.52 and a beta of 1.58. The company has a quick ratio of 1.24, a current ratio of 1.24 and a debt-to-equity ratio of 0.73.

Pediatrix Medical Group (NYSE:MD) last announced its earnings results on Tuesday, February 20th. The company reported $0.32 EPS for the quarter, topping the consensus estimate of $0.30 by $0.02. The company had revenue of $496.44 million during the quarter, compared to analysts’ expectations of $524.30 million. Pediatrix Medical Group had a negative net margin of 3.03% and a positive return on equity of 10.35%. The business’s revenue for the quarter was down 3.4% on a year-over-year basis. During the same period last year, the company posted $0.46 earnings per share. Analysts predict that Pediatrix Medical Group, Inc. will post 1.12 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of MD. Dimensional Fund Advisors LP raised its holdings in Pediatrix Medical Group by 1.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 4,409,884 shares of the company’s stock valued at $41,013,000 after buying an additional 59,336 shares in the last quarter. Pacer Advisors Inc. lifted its stake in shares of Pediatrix Medical Group by 126.9% in the fourth quarter. Pacer Advisors Inc. now owns 3,235,729 shares of the company’s stock worth $30,092,000 after buying an additional 1,809,828 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in shares of Pediatrix Medical Group by 10.0% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,634,065 shares of the company’s stock worth $15,197,000 after buying an additional 148,600 shares during the period. Invenomic Capital Management LP grew its stake in Pediatrix Medical Group by 93.3% in the 4th quarter. Invenomic Capital Management LP now owns 1,377,951 shares of the company’s stock valued at $12,815,000 after buying an additional 664,955 shares during the last quarter. Finally, Boston Partners bought a new position in Pediatrix Medical Group in the 4th quarter worth $12,452,000. 97.71% of the stock is owned by institutional investors and hedge funds.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.